Delivery Order SPE2DB20D1100-SPE2DB25FC3J8

Award Date 5/14/25
Potential Completion Date 5/15/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,475.29 firm fixed-price delivery order is for the supply of VEVYE 0.1% eye drops, a medical product. The contract has an ultimate completion date of June 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,629.70 firm-fixed-price delivery order is for the supply of "VEVYE 0.1% EYE DROP 2ML" medical products, with a period of performance through September 25, 2024. The award is not designated under any set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a firm fixed price delivery order worth $14,390.05, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the supply of a pharmaceutical product, "VEVYE 0.1% EYE DROP 2ML," with a period of performance through April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is associated with a larger indefinite delivery contract (IDC) with DLA valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $57,587.78, is for the delivery of a specific pharmaceutical product, VEVYE 0.1% Eye Drop 2ML, with a completion date of April 16, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,338.59, is for the delivery of a pharmaceutical product called "4567557411 ! VEVYE 0.1% EYE DROP 2ML". The contract is a Firm Fixed Price Delivery Order with a period of performance through March 13, 2025. There is no set-aside designation for this award. The contract is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $12,857.85, is a firm fixed price delivery order for the supply of a pharmaceutical product, specifically "4563966574 ! VEVYE 0.1% EYE DROP 2ML." The contract has an ultimate completion date of March 15, 2024 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of various pharmaceutical and medical products. The contract, valued at $1,043.55, is for the delivery of a specific medication, "VEVYE 0.1% EYE DROP 2ML", with a performance period ending on May 8, 2025. The contract is not set aside and was awarded as a firm fixed-price delivery order. Amerisourcebergen Drug Corp is the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,707.80 firm fixed-price delivery order (SPE2DX15D1053|SPE2DX25F6LSL) is for the supply of 4567847334 ! VEVYE 0.1% EYE DROP 2ML, with an ultimate completion date of April 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $8,173.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of 4564310851 ! VEVYE 0.1% EYE DROP 2ML, with a firm fixed price and an ultimate completion date of April 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This is a $3,041.88 delivery order awarded to Amerisourcebergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) on May 6, 2024. The contract is for the provision of 4564513309 ! VEVYE 0.1% EYE DROP 2ML, with a firm fixed price and an ultimate completion date of May 7, 2024. The award was made on a full and open competition basis without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that holds a $999,999,999.00...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC3J8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,083.16 fixed-price delivery order is for the supply of a specific pharmaceutical product, VEVYE 0.1% eye drops, with a performance period ending on May 15, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This contract allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

The contract award is not set aside and represents open competition. Amerisourcebergen Drug Corp is the prime contractor, and there is no mention of any major subcontractors in the provided information.

Generated 8/13/25, 11:00 AM